Inactive Instrument

Sector Chart Protalix Biotherapeutics Inc TEL AVIV STOCK EXCHANGE

Equities

US74365A1016

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
58.06B -
40.53B
38.99B
26.7B
26.56B